Insider filing · BCAX
Claire Mazumdar
Chief Executive Officer
profile →
Bicara Therapeutics Inc.
BCAX · Healthcare · 40 filings in 24 months
ticker →
Claire Mazumdar sold $776K of Bicara Therapeutics (BCAX)
Executed Nov 24 2025, disclosed Nov 25 2025, 1 day later.
Value, as filed
$776K
41,163 sh × $18.86
Executed
Nov 24 2025
the trade date, as filed
Disclosed
Nov 25 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CMClaire Mazumdar (Chief Executive Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Bicara Therapeutics Inc. (BCAX). The largest single filing was $776K of BCAX (41,163 sh × $18.86, as filed), executed Nov 24 2025.
The name
BCAXHealthcare · Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Claire Mazumdar in BCAX
BCAXSALE
Bicara Therapeutics Inc.
$280K10,000 sh × $27.98
Exec Aug 10
Filed Aug 12 · 4:19 PM ET BCAXSALE Bicara Therapeutics Inc. $283K
9,972 sh × $28.42
Exec Jul 10
Filed Jul 14 · 4:22 PM ET BCAXSALE Bicara Therapeutics Inc. $240K
12,022 sh × $19.96
Exec May 18
Filed May 20 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $354K
15,000 sh × $23.61
Exec Apr 20
Filed Apr 20 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $252K
13,404 sh across 2 lots
Exec Mar 18
Filed Mar 20 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $705K
36,766 sh × $19.17
Exec Mar 9
Filed Mar 11 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $454K
24,103 sh × $18.83
Exec Oct 16 2025
Filed Oct 20 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $467K
24,734 sh across 2 lots
Exec Oct 13 2025
Filed Oct 15 2025 · 5:30 PM ET